Company / Inventory
Twist Bioscience Corp Inventory History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$28.3M
FY2025
5-year range
$24.1M / $39.3M
FY2021-FY2025
Trend
+17.6%
vs FY2024
Sector context
#73 of 108
Health Care
What the data says
At $28M, Twist Bioscience Corp's inventory ranks #73 of 108 in the Health Care sector. Inventory returned to growth in FY2025 after 2 years of decline, reaching $28M.
Based on SEC 10-K filings.
$28M in FY2025 with a 5-year CAGR of +18.2%.
Declined from $32M to $28M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -10.4%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Sector benchmark
#73 of 108 in Health CareTop 68% of 108This company $28.3M Sector average $862.4M
▼
-96.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.2%, indicating consistent growth.
- In FY2025, inventory increased 17.6% year-over-year.
- Ranks #73 out of 108 companies in the Health Care sector.
- Peak inventory was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.3M | +17.6% |
| FY2024 | $24.1M | -24.9% |
| FY2023 | $32.1M | -18.4% |
| FY2022 | $39.3M | +23.6% |
| FY2021 | $31.8M | +158.8% |
| FY2020 | $12.3M | +67.7% |
| FY2019 | $7.3M | +21.6% |
| FY2018 | $6.0M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026